Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia
Status:
Not yet recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
This study is an open-label, single-center, dose escalation study to evaluate of safety and
efficacy of human umbilical cord -derived mesenchymal stem cells (hUC-MSCs) in children with
moderate and severe bronchopulmonary dysplasia.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital of Chongqing Medical University